Dallah reappoints Chairman, Vice Chair

Logo of Dallah Healthcare Co.

Dallah Healthcare Co.’s board of directors decided, on Oct. 22, to reappoint Tarek Alkasabi as board Chairman and Mohiuddin Kamel as Vice Chairman.

In a statement to Tadawul, Dallah said that its board of directors approved the formation of the remuneration and nominations committee, chaired by Tarek Alkasabi. The committee includes three independent and non-executive members.

The company also established the investment and finance committee, comprising board and non-board members, as well as CEO Ahmed Babaeer. The committee is also chaired by Alkasabi.

In addition, the board formed a digital transformation and IT committee, comprising independent, non-executive, and external members.

The board of directors also formed the audit committee for the new board term, which will be announced separately in line with disclosure requirements.

Dallah added that the board’s decision to form the above-mentioned committees, including the audit committee, takes effect on Oct. 21, 2025, for four years, ending on Oct. 20, 2029.

The company also appointed a board secretary, along with representatives of Dallah Healthcare Co. to the Capital Market Authority (CMA) and the Saudi Exchange (Tadawul).

According to available data from Argaam, Dallah's extraordinary general meeting (EGM) recently elected board members for the new four-year term.